Recent Advances in the Development of “Curcumin Inspired” Compounds as New Therapeutic Agents
- 16 October 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 20 (15), 1543-1558
- https://doi.org/10.2174/1389557520666200508083302
Abstract
Despite a huge body of research in the past two decades investigating the antioxidant, anti-inflammatory, antimicrobial, and anti-carcinogenic properties of curcumin (CUR), a CUR-based anti-tumor drug is yet to be developed. Lack of success in achieving this goal stems from CUR’s unfavorable biophysicochemical features, particularly poor solubility, low bioavailability, and rapid metabolism, coupled to a complex biological profile making it difficult to determine its mechanism of action. A significant body of literature aimed at improving its physicochemical properties through synthesis or by designing delivery methods have been published, and the progress in these areas have been reviewed. The present review aims to summarize recent progress in the synthesis of structurally diverse “curcumin-inspired” compounds along with computational docking and bioassay studies, through which a number of promising analogs have been identified that warrant further study.Keywords
This publication has 50 references indexed in Scilit:
- Ensemble docking and molecular dynamics identify knoevenagel curcumin derivatives with potent anti-EGFR activityGene, 2014
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing plateletsNature Medicine, 2013
- Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitorsProceedings of the National Academy of Sciences of the United States of America, 2012
- Curcumin Analogues with Potent and Selective Anti‐proliferative Activity on Acute Promyelocytic Leukemia: Involvement of Accumulated Misfolded Nuclear Receptor Co‐repressor (N‐CoR) Protein as a Basis for Selective ActivityChemMedChem, 2012
- Multitargeting by curcumin as revealed by molecular interaction studiesNatural Product Reports, 2011
- Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapyChinese Medicine, 2011
- Curcumin Inhibits the Proteasome Activity in Human Colon Cancer Cells In vitro and In vivoCancer Research, 2008
- Studies on curcumin and curcuminoids: XXXI. Symmetric and asymmetric curcuminoids: Stability, activity and complexation with cyclodextrinInternational Journal of Pharmaceutics, 2007
- Thymidylate synthase inhibitorsUpdate on Cancer Therapeutics, 2006
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005